Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations

13 Dec 2017

Abstract excerpt

Importance: Given the rapidly increasing use of stimulant medications during pregnancy and among women of reproductive age who may become pregnant inadvertently, there is a need to better understand their safety. Objective: To examine the risk of congenital malformations associated with intrauterine exposure to stimulants. Design, Setting, and Participants: Cohort study of the Medicaid-insured population in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Folate and B Vitamins Research
Share to Neuroethics, Human Enhancement, Biomedical Innovations
Share to Prenatal Substance Exposure Effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29238795
DOI: 10.1001/jamapsychiatry.2017.3644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital MalformationsPMID 29238795Read ↗

Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the childSemantic proximity Read ↗

Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital MalformationsSemantic proximity Read ↗

Risk of Adverse Pregnancy Outcomes Associated with Sodium Valproate(VPA): A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS)Semantic proximity Read ↗

Antiseizure medication use during pregnancy and children’s neurodevelopmental outcomesSemantic proximity Read ↗

PRENATAL EXPOSURE TO AMPHETAMINESSemantic proximity Read ↗

Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis.Semantic proximity Read ↗

Adverse Events During Pregnancy Associated with Third Generation Antiseizure Medications: A Real-World AnalysisSemantic proximity Read ↗

Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital MalformationsSemantic proximity Read ↗

Pharmacogenetics of drug-induced birth defects: what is known so far?Semantic proximity Read ↗

Reassessing Metformin Safety in Pregnancy: Robust Disproportionality Mining of FAERS Uncovers De-novo Teratogenic Signals Across Multiple Fetal Organ SystemsSemantic proximity Read ↗

Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in DenmarkSemantic proximity Read ↗

Maternal caffeine consumption and risk of neural tube defectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.